financetom
Business
financetom
/
Business
/
Hermes sued in antitrust class action over Birkin bag sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hermes sued in antitrust class action over Birkin bag sales
Mar 20, 2024 8:44 AM

(Reuters) - French luxury house Hermes has been sued in California over claims it unlawfully allows only customers with "sufficient purchase history" with the company to buy its famed Birkin handbags.

Hermes is violating antitrust law by "tying" the sale of one item to the purchase of another, two California residents alleged in the proposed federal class-action lawsuit filed on Tuesday in San Francisco.

The company's sales associates are driving the scheme by pushing customers to buy shoes, scarves, jewelry and other items to gain an opportunity to buy a Birkin, the lawsuit said.

Hermes and attorneys for the plaintiffs did not immediately respond to requests for comment.

The lawsuit calls the Birkin handbags, long seen as a status symbol, an "icon of fashion."

Consumers cannot purchase a Birkin online from Hermes, and the leather bags, which are handcrafted and can cost thousands of dollars each, are not displayed for sale in the company's retail stores, according to the lawsuit.

"Typically, only those consumers who are deemed worthy of purchasing a Birkin handbag will be shown a Birkin handbag (in a private room)," the lawsuit claimed.

Hermes sales associates do not earn commissions on Birkin bag sales and are instructed to use the handbags "as a way to coerce consumers to purchase ancillary products," according to the complaint.

The lawsuit said it was seeking class action status for thousands of U.S. consumers who bought Hermes goods or were asked to buy them in order to purchase a Birkin.

Hermes operates about 43 stores in the United States, including eight in California.

The plaintiffs are seeking unspecified monetary damages and a court order barring Hermes' allegedly anticompetitive practices.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US importers set to accelerate shipments to record levels on tariff, strike threats
US importers set to accelerate shipments to record levels on tariff, strike threats
Dec 9, 2024
* Importers front-load purchases due to potential port strike and tariff hikes * Retail group expects record container volumes in November and December * Trump's tariff proposals cause anxiety among retailers and importers By Siddharth Cavale NEW YORK, Dec 9 (Reuters) - The United States' busy ports kicked activity up a notch in November and December, when inbound cargo traffic...
Intuit Insider Sold Shares Worth $2,359,618, According to a Recent SEC Filing
Intuit Insider Sold Shares Worth $2,359,618, According to a Recent SEC Filing
Dec 9, 2024
05:22 PM EST, 12/09/2024 (MT Newswires) -- Mark P. Notarainni, Executive Vice President, Consumer Group, on December 05, 2024, sold 3,649 shares in Intuit (INTU) for $2,359,618. Following the Form 4 filing with the SEC, Notarainni has control over a total of 19 shares of the company, with 19 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/896878/000162828024050516/xslF345X05/wk-form4_1733782604.xml ...
Protara Therapeutics Launches Common Stock Offering; Shares Fall After Hours
Protara Therapeutics Launches Common Stock Offering; Shares Fall After Hours
Dec 9, 2024
05:25 PM EST, 12/09/2024 (MT Newswires) -- Protara Therapeutics ( TARA ) launched a public offering of common shares. Underwriters are expected to get a 30-day overallotment option for additional shares at the offering price, Protara said Monday in a statement. Net proceeds are expected to fund the clinical development of TARA-002, among other things, the company said. TARA-002 is...
Genasys Fiscal Q4 Loss Narrows, Revenue Declines
Genasys Fiscal Q4 Loss Narrows, Revenue Declines
Dec 9, 2024
05:23 PM EST, 12/09/2024 (MT Newswires) -- Genasys ( GNSS ) reported a fiscal Q4 net loss late Monday of $0.26 per diluted share, narrowing from $0.27 a year earlier. Two analysts polled by FactSet expected a loss of $0.11. Revenue for the quarter ended Sept. 30 declined to $6.7 million from $10.7 million a year earlier. Three analysts surveyed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved